Showing 2,034 articles by Keith Alcorn

Filters Content type: News, About HIV Author: Keith Alcorn

Keith joined the editorial team of the National AIDS Manual (NAM) in 1991, launched the aidsmap website in 1998 and was the Senior Editor of NAM and aidsmap until 2018. He now contributes news and conference reports as a freelancer.

Starting HAART at CD4 above 350 does not give better T-cell response

News
11 March 2003

Non-profit collaboration pioneers new resistance interpretation system

News
5 March 2003

Good adherence predicts lipodystrophy in Italian cohort

News
4 March 2003

HIV DNA vaccine: volunteers sought for London study

News
3 March 2003

HIV lipodystrophy case definition: full details published

News
3 March 2003

TAC accuses South African govt of back pedalling on treatment promise

News
26 February 2003

Tenofovir approved for first-line therapy in European Union

News
25 February 2003
The search for an HIV prevention vaccine

HIV vaccine fails in first large trial; may protect Blacks, Asians only

News
24 February 2003

T-20 to sell at 18,980 euros: most expensive HIV drug yet

News
24 February 2003

Tipranavir shows activity for PI-resistant patients

News
24 February 2003

Early lipid increases on HAART represent return to normal level for age group

News
18 February 2003

Single class therapy may be enough to control HIV in some drug-resistant patients

News
14 February 2003

2NN study shows nevirapine equal to efavirenz, but has better lipid profile

News
14 February 2003

Generic nevirapine: quality control reports show good results

News
13 February 2003

CD4-guided treatment interruption reduces time on therapy by two-thirds

News
13 February 2003

ddI dosing with tenofovir defined

News
13 February 2003

New antiretrovirals: `pipeline at its fullest for years`

News
11 February 2003

New protease inhibitor TMC 114 effective for PI-exhausted patients in early study

News
11 February 2003

Atazanavir and amprenavir both pitching for first line therapy with new resistance data

News
11 February 2003

T-1249 could salvage T-20 failure

News
11 February 2003

Thai AIDS death rate halved using sub-optimal therapy

News
6 February 2003

Indian company launches generic version of abacavir

News
5 February 2003
Cardiovascular disease

Lipid increase not needed for HIV protease inhibitors to trigger cardiovascular problems

News
4 February 2003
Bone & joint problems

Advanced HIV disease has stronger link to bone mineral loss than HAART

News
3 February 2003